MYLOVASC

This brand name is authorized in Nigeria.

Active ingredients

The drug MYLOVASC contains one active pharmaceutical ingredient (API):

1
UNII 885H5YC40L - LEVAMLODIPINE BESYLATE
 

Levamlodipine is the pharmacologically active isomer of amlodipine, a long-acting calcium channel blocker. It is used for the treatment of hypertension in adults and pediatric patients, to lower blood pressure.

 
Read more about Levamlodipine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-9649 Tablet Mylovasc 2.5 Tablet TAB 2.5 mg 3 x 10's 88 RNW-PP-372797 MYLOVASC 2.5 TABLET S -AMLODIPINE 2.5 MG S-Amlodipine 2.5 Crospovidoine ,Soduim Starch Glycolate,Soduim Acid citrate Collodial Anhydrous ,Magnesuim Sterate A4-9649 Drugs Imported Products 310 POM 1 10/23/2023 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, PLOT 122-123 AFRIPRINT ESTATE, ISOLO BAFNA PHARMACEUTICALS LTD., No 147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai- 600 052, India., India 27/03/2024
A4-9650 Tablet MYLOVASC 5MG TAB 5 mg 3x10 87 RNW-PP-371587 MYLOVASC 5MG S-AMLODIPINE BESILATE TABLETS 5MG S- Amlodipine Micro crystalline' Croscarmellose,Soduim Acid,Collodial Anhydrous Magnesuim sterate A4-9650 Drugs Imported Products 310 POM 1 10/17/2023 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, PLOT 122-123 AFRIPRINT ESTATE, ISOLO BAFNA PHARMA LIMITED, 147 MADHAVARAM RED HILLS ROAD GRANTLYON VILLAGE VADAKARI CHENNAI TAMIL, NADU INDIA, India 27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C08CA17 C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-9649, A4-9650

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.